CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 318.00
+6.00 (1.92%)
Oct 6, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.31 billion as of October 6, 2026. Its market cap has decreased by -43.33% in one year.
Market Cap
6.31B
Enterprise Value
1.53B
Revenue
3.67B
Ranking
n/a
PE Ratio
90.06
Stock Price
318.00
ChartMarket Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.31B, a decrease of -53.17%. That is a compound annual growth rate of -10.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 6.31B | -20.19% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J-Pharma | 7.81B |
| StemCell Institute | 7.53B |
| ADR Biomedical Holdings | 6.97B |
| SUSMED,Inc. | 6.91B |
| MEDINET | 6.81B |
| BrightPath Biotherapeutics | 6.67B |
| Cyfuse Biomedical K.K. | 6.37B |
| TMS Co., Ltd. | 5.94B |